Niklaus Schaefer

Prizes and Awards last 10 years - Aug 2024 2024 Society of Nuclear Medicine Annual Meeting Best International Abstract “CD206 Scintigraphy/SPECT Imaging of Immunosuppressive Macrophages: A Potential Predictor for Immunotherapy Outcomes in Melanoma” 2023 National Meeting Society of Nuclear Medicine (SGNM), Best Oral Presentation “CD206 Imaging in Melanoma” 2022 CVIR Award Most cited article Clinical investigation “Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results… Show more 2024 Society of Nuclear Medicine Annual Meeting Best International Abstract “CD206 Scintigraphy/SPECT Imaging of Immunosuppressive Macrophages: A Potential Predictor for Immunotherapy Outcomes in Melanoma” 2023 National Meeting Society of Nuclear Medicine (SGNM), Best Oral Presentation “CD206 Imaging in Melanoma” 2022 CVIR Award Most cited article Clinical investigation “Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicenter Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT)” 2022 National Meeting Society of Nuclear Medicine (SGNM), Poster prize “Outpatient Yttrium-90 microsphere radioembolization: assessment of radiation safety and quantification of posttreatment adverse events causing hospitalization” 2022 Society of Nuclear Medicine Annual Meeting, Alavi-Mandell Award “Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and 18F-FDG PET/CT in Correlation with Clinical Pathologic Outcome” 2019 National Meeting Society of Nuclear Medicine (SGNM), Poster prize “First experience of cytoreduction in chronic lymphoid leukemia with 177Lu-DOTATATE” 2018 European Association of Nuclear Medicine (EANM), Nomination Marie Curie Award “18F-FDG PET metabolic to-morphological volume ratio predicts PD-L1 tumor expression and response to PD-1 blockade in lung cancer” 2018 European Association of Nuclear Medicine (EANM), Nomination Marie Curie Award “First-in-Human Study with 18F-Azafol for Folate Receptor Targeted PET” 2018 Society of Nuclear Medicine Annual Meeting Best International Abstract “18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumor expression and response to PD-1 blockade in lung cancer” 2015 Society of Nuclear Medicine Annual Meeting, Alavi-Mandell Award “Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer” Show less

Competitive Grants last 10 years - Total funds received Swiss National Foundation as Applicant: 4’121’786 CHFTotal funds received Swiss National Foundation as Clinical Partner: 249’140 CHF Other external total funding as Applicant: 616’000 CHFTotal Funding received as Co-Applicant: 6’773’077 CHF

Worlds Best Hospitals Newsweek 2019 CHUV ranked #9 worldwide in Best Hospitals Ranking